Monthly Merger Review Snapshot
European enforcers cut a deal clearing a $21.4 billion biotech transaction while their U.S. peers approved several multibillion-dollar tie-ups only to launch unusual challenges against two other mergers....To view the full article, register now.
Already a subscriber? Click here to view full article